Skip to content
Devyser
Menu
  • Products
    • Hereditary
      • Thalassemia
        • Devyser Thalassemia NGS
      • Cystic Fibrosis
        • CFTR – Allele Specific
        • Devyser CFTR NGS
      • Familial Hypercholesterolemia
        • Devyser FH NGS
      • Prenatal Aneuploidy
        • Aneuploidy QF-PCR
      • Y Chromosome Microdeletion
        • Devyser AZF
      • Miscarriage Analysis
        • Aneuploidy QF-PCR
        • Devyser Thrombophilia
        • Devyser HFE
        • Devyser CVD
    • Oncology
      • Breast and Ovarian Cancer
        • Devyser BRCA NGS
        • Devyser HBOC NGS
    • Transplantation
      • Devyser Chimerism NGS
    • Accessories
      • Capillary Electrophoresis
        • Devyser DEV-5 Dye Set
        • 560 Sizer Orange
      • Next Generation Sequencing
        • Devyser Library Clean
        • Devyser Index Plate A
    • Close
  • Order Kits
    • Order Products
    • Distributors
    • Close
  • Resources
    • Updates
      • Events
      • Articles
      • Company News
    • Tools
      • Sequence Coverage Calculator
    • Downloads
      • Whitepapers
      • IFU and Software Settings
      • Batch Release Certificates
    • Close
  • Company
    • About Us
    • Board of Directors
    • Management Team
    • News
    • Career
    • Close
  • Contact
    • Contact Devyser
    • Book a demo
    • Support
    • Distributors
    • Close
Distributor login

SPGH Coimbra

Events / By Emily Carter
Published: November 15, 2019

Today we’re in Coimbra at #SPGH with our local distributor @Bioportugal – Químico, Farmacêutica, Lda. to answer your questions about our testing kits in #breastandovariancancer , #prenatalaneuploidytesting & more! #geneticahumana
#devyser #genetictesting #NGS

View all events

Post navigation

← Previous Post
Next Post →

Recent Posts

  • Major health care providers in Latin America implement Devyser’s solutions to improve post-transplant healthcare management
  • Cancer doesn’t take a break, neither do we
  • Devyser at DGTI 2020
  • Devyser welcomes Fredrik Alpsten as new CEO
  • Devyser’s breakthrough NGS product for hereditary breast and ovarian cancer testing now approved for diagnostic use in the EU

Archives

  • Products
    • Hereditary
    • Transplantation
    • Reproductive Health
    • Oncology
    • Accessories
  • Order Kits
    • Distributors
  • Resources
    • Articles
    • Calculator
    • Events
  • Downloads
    • Whitepapers
    • IFU and Software settings
    • Certificates
  • Company
    • About Us
    • Board of Directors
    • Management Team
    • Career
    • News
  • Contact
    • Support
Copyright © 2020 Devyser. All rights reserved. Privacy policy | Cookies
  • Home
  • Products
    • Hereditary
      • Devyser Thalassemia NGS
      • CFTR – Allele Specific
      • Devyser CFTR NGS
      • Devyser FH NGS
      • Aneuploidy QF-PCR
      • Devyser AZF
      • Devyser Thrombophilia
      • Devyser HFE
      • Devyser CVD
      • Back
    • Oncology
      • Devyser BRCA NGS
      • Devyser HBOC NGS
      • Back
    • Transplantation
      • Devyser Chimerism NGS
      • Back
    • Accessories
      • Devyser DEV-5 Dye Set
      • 560 Sizer Orange
      • Devyser Library Clean
      • Devyser Index Plate A
      • Back
    • Back
  • Order Kits
    • Order products
    • Distributors
    • Back
  • Resources
    • Updates
      • Events
      • Articles
      • Company News
      • Back
    • Calculator
    • Downloads
      • Whitepapers
      • IFU and Software settings
      • Certificates
      • Back
    • Back
  • Company
    • About us
    • Board of Directors
    • Management Team
    • Career
    • News
    • Back
  • Contact
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site, you understand and agree to this.I understandRead more